<?xml version="1.0" encoding="UTF-8"?>
<p>The biology of influenza viruses and coronaviruses inevitably leads to the appearance of new pandemic strains; it is impossible to predict the moment of their development, genomic variability and antigenic properties. This means that pandemics of new respiratory infections will always start in the absence of immune prophylactics and treatments. This underlines the necessity of prior research and development of treatments for the prevention and treatment of respiratory viral infections and in particular for coronaviruses and influenza A viruses. Several antiviral drugs that will be described herein are presented in TableÂ 
 <xref rid="tbl3" ref-type="table">3</xref>.
</p>
